The increasing popularity of GLP-1 drugs like Mounjaro and Ozempic is leading to a surge in demand for hair treatment products, as hair loss is a common side effect. Companies are responding with innovative solutions, and experts predict continued growth in this market as GLP-1 usage expands.
GLP-1 Drugs Fuel Boom in Hair Treatment Market as Side Effect Concerns Rise
A common side effect of popular GLP-1 drugs like Mounjaro and Ozempic – hair loss – is creating a significant growth opportunity for the hair treatment industry. Companies such as Redken, Nutrafol, and KeraFactor are innovating and marketing products to address this issue, while retailers like Ulta are reporting increased customer demand.
The surge in GLP-1 usage, driven by their effectiveness in weight loss, is expected to continue. JPMorgan estimates that 25 million Americans will be on a GLP-1 by 2030, up from 5 million in 2023. This growth is attracting investment and innovation in the hair treatment space.
The Link Between GLP-1s and Hair Loss
Users like Branneisha Cooper experienced hair loss approximately a year after starting Mounjaro. Experts explain that rapid weight loss and potential nutrient deficiencies associated with GLP-1s can contribute to hair thinning. Consumers are turning to increased protein intake, vitamins, and specialized haircare products to combat this side effect.
Industry Response and Opportunities
Circana estimates that households using GLP-1 drugs spend 30% more on beauty products than those who don't. This trend is driving demand for at-home growth treatments, scalp serums, and supplements. Brands are responding with targeted products and marketing campaigns.
- Redken launched the Acidic Grow Full System, specifically tested on GLP-1 users.
- Nutrafol is seeing increased demand for its hair health products.
- KeraFactor is experiencing 100% year-over-year growth in direct-to-consumer sales.
Ulta CEO Kecia Steelman noted increased consumer purchases of hair treatment products linked to the GLP-1 trend. Experts believe the market's size and the potential for customer loyalty make it an attractive investment opportunity.
Looking Ahead
The hair loss associated with GLP-1s is a significant concern for the beauty industry. Companies are focusing on preventative solutions and personalized treatments. While the hair loss can be alarming, many users, like Cooper, report that their hair eventually recovers. The convergence of health, wellness, and beauty presents a unique opportunity for growth and innovation in the hair treatment market.
